Full-Time

Quality Systems Engineer

Updated on 8/1/2026

Nudge

Nudge

11-50 employees

Non-invasive neuromodulation headset via ultrasound

No salary listed

San Francisco, CA, USA

In Person

Category
QA & Testing (1)
Required Skills
Risk Management

Get referred to Nudge

See people who can refer or advise you

Requirements
  • At least 2 years of industry experience.
  • Experience with design controls, product and process validation, and risk management.
  • A degree in an engineering or scientific discipline, such as biomedical engineering, electrical engineering, or neuroscience, or equivalent hands-on experience.
  • Familiarity with Good Clinical Practice and human factors.
  • Familiarity with the FDA Quality Management System Regulation, ISO 13485, and ISO 14971.
  • Experience conducting risk management activities using tools such as failure mode and effects analysis.
  • Strong technical writing skills.
  • High integrity and strong professional judgment.
Responsibilities
  • Ensure that new and existing product designs and processes meet all internal and regulatory requirements for safety and performance.
  • Partner in new product development by leading quality-critical discussions, influencing key decisions, and driving necessary process changes across design controls, investigational studies, and clinical trials.
  • Manage multiple tasks and drive execution of change orders.
  • Initiate or support corrective and preventive actions and non-conformances, lead investigations, and implement mitigations.
  • Represent and cultivate a culture of quality by working with interdisciplinary teams to set expectations, identify gaps, and meet a high internal standard for rigor.

Generate a concise company summary answering: 1) what the company does, 2) how its product works, 3) how it differs from competitors, 4) its goal, based on the provided description.

Company Size

11-50

Company Stage

Series A

Total Funding

$100M

Headquarters

San Francisco, California

Founded

2025

Get referred to Nudge

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • US $100M Series A led by Thrive and Greenoaks enables top talent recruitment and clinical trials.
  • Nudge Zero, a human-ready system, passed testing three months ago toward clinical validation.
  • EU and US regulatory shifts validate at-home neuromodulation, boosting consumer and healthcare market access.

What critics are saying

  • EU Class III reclassification for non-medical brain stimulation blocks consumer cognitive enhancement pathways.
  • Unproven regulatory path for focused ultrasound may delay FDA clearance for essential tremor and other conditions.
  • Brand confusion with Nudge Security's corporate control products erodes B2C trust and appeals.

What makes Nudge unique

  • Nudge uses focused ultrasound for non-invasive, MRI-verified deep brain circuit modulation.
  • Its dual-purpose device stimulates and images the brain simultaneously with precise targeting.
  • Nudge targets anxiety, OCD, depression, addiction, and chronic pain via neuromodulation.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

18%
EquityBulls
Aug 12th, 2025
FSN E-Commerce acquires 40% Nudge stake

FSN E-Commerce Ventures Ltd has approved the acquisition of the remaining 40% stake in Nudge Wellness Pvt Ltd from Onesto Labs Pvt Ltd, as per the terms of a shareholders' agreement from April 2022. Onesto will no longer hold any stake in Nudge post-transaction. FSN's stock traded at ₹203.60 on BSE, with a high of ₹204.25 and a low of ₹200.25, and a net turnover of ₹9.53 million.

Nudge
Jul 25th, 2025
Announcing Nudge's $100M Series A Fundraise

Nudge - Whole-brain interfaces for everyday life